CANbridge
formerly CANbridge PharmaceuticalsIPOBringing transformative therapies to rare disease patients in China and beyond
Public · Burlington, China · Founded 2012 · $211.0M raised
- Headquarters
- Burlington
- Employees
- 201–500
- Founded
- 2012
- Business Model
- B2B
- Website
- canbridgepharma.com
- Total Funding
- $211.0M
- Last Round
- $43.0M Series EDec 2020
- Rounds
- 6
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
CANbridge Pharmaceuticals (HKEX: 1228) is a global biopharmaceutical company with a foundation in China, committed to the research, development, and commercialization of rare disease therapeutics. The company has a differentiated drug portfolio with 3 approved drugs and a pipeline of 7 clinical assets, focusing on prevalent rare disease indications including mucopolysaccharidosis, Gaucher disease, and other rare genetic disorders. CANbridge operates a Next-Generation Innovation and Process Development Facility developing novel gene therapies, and partners globally with leading biotech and pharma companies to bring treatments to patients in China and worldwide.
Summary
CANbridge is a Biotech company based in Burlington, China, founded in 2012. It has raised $211.0M in total across 6 rounds, most recently a $43.0M Series E round in Dec 2020. Investors include Qiming VP, Hong Kong Stock Exchange and Lapam Capital.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Dec 2021
Sign up to see all 7 events
Funding: Series A through Series E. Amounts, valuations, and investors where available.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Calico researches human aging using advanced technologies and model systems, applying that knowle...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/canbridge"><img src="https://indexed.vc/api/badge/company/canbridge" alt="CANbridge on Indexed.vc" width="260" height="76" /></a>